Aimei Health Technology Co., Ltd. (AFJK) company profile
Close on Nov 17, 2026Market cap $37.49MP/E –Yield –
About Aimei Health Technology
Blank Checks, SIC 6770
Aimei Health Technology Co., Ltd. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more operating entities. The organization focuses primarily on targeting small-cap businesses within the healthcare landscape, specifically across the biopharmaceutical, medical technology, medical device, and diagnostic or related services sectors. As an acquisition vehicle, it does not manufacture commercial products or deliver consumer services directly to clients or end customers.
The company is incorporated in the Cayman Islands as an exempted company and maintains its principal executive offices in New York, New York. Its operational reach and search efforts for identifying potential business combination candidates are not restricted to any particular geographic location.
Summary of the business section of Aimei Health Technology's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Aimei Health Technology Co., Ltd.
- Founded
- 2023
- Headquarters
- New York, NY
- Address
- 10 East 53rd Street, Suite 3001 10022
- Phone
- 34 678 035200
- Industry
- Blank Checks
- Fiscal year ends
- December 31
- Auditor
- MaloneBailey, LLP, Houston, Texas
Stock & identifiers
- Ticker
- AFJK
- Other tickers
- AFJKR, AFJKU
- Exchange
- Nasdaq
- IPO date
- Dec 5, 2023
- Shares outstanding
- 3M, Aug 13, 2026
- Public float
- $44.55M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- SEC CIK
- 1979005
- FIGI
- BBG01KH0P454
- Share class FIGI
- BBG01KH0P515
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Daniel Veikko Polvi | Director | – |
IPO
From the final prospectus (Form 424B4) and the first day of trading
SPAC offering
- Type
- SPAC (blank check) IPO of units
- Final prospectus filed
- Dec 5, 2023
- Securities offered
- 6,000,000
- First trading day
- Dec 4, 2023
- First-day close
- $10.15
- Lock-up ends (est.)
- Jun 1, 2024
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Aug 25, 2026 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| May 20, 2026 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Apr 21, 2026 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Apr 1, 2026 | Late filing | Notification of late filing |
| Nov 14, 2025 | Late filing | Notification of late filing |
| Dec 5, 2023 | IPO | Initial public offering priced (424B4 prospectus) |
| Nov 30, 2023 | Listing | Registration of securities on an exchange (Form 8-A) |
See a number that looks wrong?